10x Genomics acquired Proteintech Genomics (a division within Proteintech Group), a transaction completed in June 2026.
Proteintech Genomics (a division within Proteintech Group) operates in Proteomics / single cell and spatial biology. Proteintech Genomics develops high-plex proteomic solutions for single cell and spatial applications that run on 10x Genomics platforms, including its Human Discovery Panel — described as the largest antibody-based single cell protein panel — which supports integrated analysis of intracellular proteins, cell-surface proteins, and transcriptomic profiles and is compatible with Flex chemistry, including the Flex Apex assay. 10x Genomics acquired it to expand its proteomics capabilities and enable richer multiomic analysis across its single cell and spatial platforms, including protein capabilities planned for the recently launched Atera platform. Proteintech Genomics CEO Dr. Kristopher Nazor and team joined 10x Genomics.
Strategically expand 10x Genomics' proteomics capabilities and support its broader vision for multiomic approaches that integrate transcriptomic and proteomic information at the single cell and spatial levels.
Advisory firms were not disclosed for this transaction.